Literature DB >> 9933106

Cellular and molecular changes accompanying the progression from insulitis to diabetes.

I André-Schmutz1, C Hindelang, C Benoist, D Mathis.   

Abstract

Insulin-dependent diabetes mellitus (IDDM) is not a disease of unbridled destruction. The autoimmune attack on pancreatic beta cells has two distinct stages - insulitis and diabetes - and progression of the former to the latter appears to be highly regulated. Identifying the factors controlling this transition has been difficult because it is a complex process that occurs non-universally and asynchronously. We have overcome these difficulties by coupling a simplified TCR transgenic (tg) model of IDDM and the immunosuppressive drug cyclophosphamide (CY). Young BDC2.5 TCR tg mice show insulitis but not diabetes; CY treatment provoked diabetes in 100% of animals with rapid, highly reproducible kinetics. This allowed a detailed temporal analysis of changes in cellular organization and cytokine gene expression within the lesion. The monokines IL-18, IL-12 and TNF-alpha were pivotal, their induction occurring almost immediately and their coordinate action being required for the onset of aggression. Other cytokines with direct toxicity for beta cells, including IL-1 -beta, IL-6 and IFN-gamma, were subsequently induced; in contrast, there was no cellular or molecular evidence of cell contact-mediated mechanisms of beta cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933106     DOI: 10.1002/(SICI)1521-4141(199901)29:01<245::AID-IMMU245>3.0.CO;2-O

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes.

Authors:  Stuart E Turvey; Eric Swart; Maria C Denis; Umar Mahmood; Christophe Benoist; Ralph Weissleder; Diane Mathis
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

2.  In utero undernutrition reduces diabetes incidence in non-obese diabetic mice.

Authors:  A Oge; E Isganaitis; J Jimenez-Chillaron; C Reamer; R Faucette; K Barry; R Przybyla; M E Patti
Journal:  Diabetologia       Date:  2007-03-17       Impact factor: 10.122

Review 3.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

4.  Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse.

Authors:  D Bobbala; X-L Chen; C Leblanc; M Mayhue; J Stankova; T Tanaka; Y-G Chen; S Ilangumaran; S Ramanathan
Journal:  Diabetologia       Date:  2012-08-14       Impact factor: 10.122

5.  Apoptosis in autoimmune diabetes: the fate of beta-cells in the cleft between life and death.

Authors:  Charles Sia; Arno Hänninen
Journal:  Rev Diabet Stud       Date:  2006-05-10

6.  Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity.

Authors:  Laurent Poirot; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

7.  Imaging dynamics of CD11c⁺ cells and Foxp3⁺ cells in progressive autoimmune insulitis in the NOD mouse model of type 1 diabetes.

Authors:  Anja Schmidt-Christensen; Lisbeth Hansen; Erwin Ilegems; Nina Fransén-Pettersson; Ulf Dahl; Shashank Gupta; Asa Larefalk; Tine D Hannibal; Alexander Schulz; Per-Olof Berggren; Dan Holmberg
Journal:  Diabetologia       Date:  2013-08-21       Impact factor: 10.122

8.  Beta cell MHC class I is a late requirement for diabetes.

Authors:  Emma E Hamilton-Williams; Stephanie E Palmer; Brett Charlton; Robyn M Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-15       Impact factor: 11.205

9.  Prevention of type 1 diabetes by gene therapy.

Authors:  Chaorui Tian; Jessamyn Bagley; Nathalie Cretin; Nilufer Seth; Kai W Wucherpfennig; John Iacomini
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Interleukin-21 is required for the development of type 1 diabetes in NOD mice.

Authors:  Andrew P R Sutherland; Tom Van Belle; Andrea L Wurster; Akira Suto; Monia Michaud; Dorothy Zhang; Michael J Grusby; Matthias von Herrath
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.